Gary Walsh, PhD

Limerick City

Ireland

Associate Professor in the Industrial Biochemistry Program at the University of Limerick. He is also a member of BioPharm International's Editorial Advisory Board.

Articles

Biopharmaceuticals: Approvals and Approval Trends in 2004

Cancer remains the primary indication (three products), again mirroring recent approval trends.

Modern Antibody-Based Therapeutics

As of late 2004, 26 modern antibody-based therapeutic agents have been approved in the European Union and the US. Some 500 such products are currently in development, ensuring that the number of approved antibody-based products will increase substantially over the coming years.